2-Guanidine-4-methylquinazoline acts as a novel competitive antagonist of A type γ-aminobutyric acid receptors.
Neuropharmacology
; 75: 126-37, 2013 Dec.
Article
en En
| MEDLINE
| ID: mdl-23916476
Palabras clave
2-guanidine-4-methylquinazoline; 6-cyano-7-nitroquinoxaline-2,3-dione; A type γ-aminobutyric acid receptor; ACSF; ACh; AMPAR; ASIC; Bic; CNQX; Competitive antagonist; D(−)-2-amino-5-phosphonopentanoic acid; D-AP5; DMEM; DR; Dulbecco's Modified Eagle's Medium; GABA; GABA(A) receptor; GABA(A)R; GLIC; GMQ; Gloeobacter ligand-gated ion channel; HBSS; HEPES; Hank's Buffered Salt Solution; I-V; N-hydroxyethylpiperazine-N-2-ethanesulphonic acid; N-methyl-D-aspartic acid receptor; NMDAR; PS; TTX; acetylcholine; acid-sensing ion channel; artificial cerebrospinal fluid; bicuculline-methobromide; current-voltage; dose ratio; fEPSPs; field excitatory postsynaptic potentials; mIPSC; miniature inhibitory postsynaptic current; nAChR; nicotinic acetylcholine receptor; population spike; tetrodotoxin; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; γ-aminobutyric acid
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Quinazolinas
/
Receptores de GABA-A
/
GABAérgicos
/
Guanidinas
/
Neuronas
Límite:
Animals
/
Humans
Idioma:
En
Año:
2013
Tipo del documento:
Article